Magnesium Sulfate and Fentanyl for Facilitating Awake Fiberoptic Nasotracheal Intubation: A Randomized Study

2019 ◽  
Vol 4 (1) ◽  
Author(s):  
Shweta Dhiman ◽  
Anju Romina Bhalotra ◽  
Ruchi Kumari ◽  
Kavita Rani Sharma ◽  
Uttam Chand Verma
2017 ◽  
Vol 9 (2) ◽  
pp. 84-87 ◽  
Author(s):  
Imam Bano ◽  
Pramod R Gade ◽  
Yasir Alvi

ABSTRACT Objective To assess the effectiveness of discontinuation of magnesium sulfate (MgSO4) infusion in patients with severe preeclampsia immediately postdelivery. Materials and methods In a prospective-randomized study, women with severe preeclampsia attending the Jawaharlal Nehru Medical College, Aligarh, India, between January 2013 and September 2014 were enrolled. The inclusion criteria were blood pressure of at least 160/110 mm Hg after 24 weeks and either of the following: Proteinuria (dipstick value. 1), platelet <100,000, and serum transaminase levels twice as normal. Participants were assigned to control and study groups according to the time of enrollment (6-month blocks). All patients received MgSO4 loading dose (4 gm intravenously), followed by maintenance doses (1 gm/hour) until delivery (study group) and 24 hours (control group). The primary outcome was occurrence of convulsions after completion of MgSO4 therapy. Patients with treatment failure were excluded from analyses. Results Analyses included 48 patients in the study group and 43 patients in the control group. No convulsions occurred in either group after the completion of treatment. Conclusion: For women with severe preeclampsia, discontinuing MgSO4 immediately after delivery could effectively prevent convulsions. How to cite this article Anjum S, Gade PR, Garg N, Bano I, Alvi Y. Maternal Outcome with Discontinuation of Magnesium Sulfate immediately Postpartum in Severe Preeclampsia. J South Asian Feder Obst Gynae 2017;9(2):78-81.


2017 ◽  
Vol 67 (1) ◽  
pp. 50-56 ◽  
Author(s):  
Fabricio Tavares Mendonça ◽  
Lucas Macedo da Graça Medeiros de Queiroz ◽  
Cristina Carvalho Rolim Guimarães ◽  
Alexandre Cordeiro Duarte Xavier

2013 ◽  
Vol 21 (6) ◽  
pp. 98-104
Author(s):  
A.V. Marachkou ◽  
◽  
A.L. Lipnitski ◽  

2006 ◽  
Vol 13 (04) ◽  
pp. 669-675
Author(s):  
ZAHID MEHMOOD CHEEMA ◽  
MANZAR ZAKARIA ◽  
NOMAN ALI MALIK

Objective: Blind Nasotracheal Intubation (BNI) can be undertaken aftermuscle relaxation with Inj. Succinylcholine or under deep inhalational anesthesia. The objective of study was todetermine the preferred one of these 2 techniques of BNI. Design: Prospective, randomized study. Place andDuration of Study: PNS SHIFA, Karachi and AFID, Rawalpindi from May 2002 to April 2005. Subjects and Methods:Sixty patients between 10 - 40 years of age presenting for elective surgery in whom BNI was required due to limitedor no mouth opening were enrolled through convenient sampling. Patients were randomly divided into two groups:WMR (n=30) or NMR (n=30) to undergo BNI after relaxation with Succinylcholine or under inhalational anesthesia with2% Halothane, respectively. A red rubber nasal endotracheal tube (cuffed and un cuffed in adults and childrenrespectively) was used. Results: The frequency of successful BNI in WMR group was 100% and significantly higher(P=0.03) than in the NMR group (86%). Time to succeed was significantly less in the WMR group 2±0.9 minutes versus3.4±2.0 in the NMR group. There was no statistically significant difference of occurrence of adverse events in the twogroups. Conclusion: BNI with Succinylcholine produced a higher success rate. This technique can decrease failureto intubate, we speculate that it may, therefore, increase patient safety.


2016 ◽  
Vol 38 (1) ◽  
pp. 31-38 ◽  
Author(s):  
Jiehao Sun ◽  
Riyong Zhou ◽  
Wendong Lin ◽  
Jiahao Zhou ◽  
Weijan Wang

Sign in / Sign up

Export Citation Format

Share Document